These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26845881)

  • 21. Retinoblastoma: evidence for stage-based chemotherapy.
    Chung CY; Medina CA; Aziz HA; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):63-75. PubMed ID: 25436494
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy for Malignant Intraocular Tumors.
    Shah CP; Shields CL; Shields JA
    Dev Ophthalmol; 2016; 55():337-43. PubMed ID: 26501748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's New in Intra-Arterial Chemotherapy for Retinoblastoma?
    Abramson DH; Francis JH; Gobin YP
    Int Ophthalmol Clin; 2019; 59(2):87-94. PubMed ID: 30908282
    [No Abstract]   [Full Text] [Related]  

  • 24. Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma.
    Lubiński W; Zajaczek S; Sych Z; Penkala K; Palacz O; Lubiński J
    Ophthalmic Genet; 2002 Jun; 23(2):99-107. PubMed ID: 12187428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual prognosis of retinoblastoma in the posterior pole treated with primary chemotherapy plus local treatments.
    Kim JM; Kim JH; Kim SJ; Park KD; Shin HY; Ahn HS; Yu YS
    Korean J Ophthalmol; 2010 Dec; 24(6):347-52. PubMed ID: 21165233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
    Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma.
    Gobin YP; Dunkel IJ; Marr BP; Francis JH; Brodie SE; Abramson DH
    PLoS One; 2012; 7(9):e44322. PubMed ID: 23028521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
    Shields CL; Materin MA; Shields JA
    Arch Ophthalmol; 2005 Nov; 123(11):1610-2. PubMed ID: 16286630
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma.
    Winter U; Buitrago E; Mena HA; Del Sole MJ; Laurent V; Negrotto S; Francis J; Arana E; Sgroi M; Croxatto JO; Djaballah H; Chantada GL; Abramson D; Schaiquevich P
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4382-93. PubMed ID: 26176875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma.
    Santapuram PR; Schremp EA; Friedman DL; Koyama T; Froehler MT; Daniels AB
    Ophthalmol Retina; 2021 Mar; 5(3):309-312. PubMed ID: 32920208
    [No Abstract]   [Full Text] [Related]  

  • 31. Superselective intraophthalmic artery chemotherapy: what we do not know.
    Wilson MW; Haik BG; Dyer MA
    Arch Ophthalmol; 2011 Nov; 129(11):1490-1. PubMed ID: 22084220
    [No Abstract]   [Full Text] [Related]  

  • 32. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
    Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full-field electroretinography under general anesthesia in retinoblastoma.
    Sachidanandam R; Krishnakumar S; Gopal L; O'Brien JM; Khetan V; Sen P
    Doc Ophthalmol; 2013 Apr; 126(2):149-57. PubMed ID: 23288585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
    Levin AM; Francis JH; McFadden M; Brodie S; Gobin YP; Abramson DH
    PLoS One; 2019; 14(1):e0210647. PubMed ID: 30650131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
    Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
    Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative Chemotherapeutic Agents for the Treatment of Retinoblastoma Using the Intra-Arterial and Intravitreal Routes: A Path Forward Toward Drug Discovery.
    Yuan S; Friedman DL; Daniels AB
    Int Ophthalmol Clin; 2017; 57(1):129-141. PubMed ID: 27898619
    [No Abstract]   [Full Text] [Related]  

  • 39. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term visual outcome following chemoreduction for retinoblastoma.
    Demirci H; Shields CL; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.